Biothorpe is a biotechnology company focused on the development of siRNA, antisense and other molecular technologies for the treatment of cancer.
Biothorpe is working to research and develop innovative treatments that could reach millions of patients. From Acute Myelogenous Leukemia and B-Cell Lymphoma to Chronic Lymphocytic Leukemia, our research is helping to shape the future of cancer therapeutics.
Biothorpe’s intellectual property represents some of the industry's leading technologies that could result in major treatments. We strongly believe that partnerships and strategic alliances can help achieve significant impact through collaborative drug discovery and development.
Biothorpe Pharmaceuticals is a biotechnology company
focused on the development of cancer therapeutics.